Suppr超能文献

嗅觉障碍预示着疑似药物性帕金森综合征潜在的多巴胺能缺陷。

Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.

作者信息

Morley James F, Cheng Gang, Dubroff Jacob G, Wood Stephanie, Wilkinson Jayne R, Duda John E

机构信息

Parkinson's Disease Research Education Clinical and Education Center Corporal Michael J. Crescenz VA Medical Center Philadelphia Pennsylvania USA.

Department of Neurology University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA.

出版信息

Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.

Abstract

Drug-induced parkinsonism (DIP) is common, and the motor symptoms can be indistinguishable from Parkinson's disease (PD). When symptoms persist after drug withdrawal, this may represent "unmasking" of underlying PD. We previously reported that hyposmia, a common nonmotor feature of PD, was associated with persistent DIP. Here, we report on a series of 33 consecutive patients who underwent dopamine transporter imaging to evaluate DIP. We examined the clinical correlates of underlying dopaminergic denervation by comparing subjects with normal and abnormal scans. Imaging was abnormal in 7 of 33 (21%) cases. Motor features were similar in patients with normal and abnormal scans. Olfactory testing was available for 30 subjects and was concordant with imaging in 27 of 30 (odds ratio = 63; 95% confidence interval: 4.8-820; = 0.002). Olfactory testing may be a simple screen to help identify DIP patients with underlying dopaminergic denervation, consistent with unmasking of incipient PD.

摘要

药物性帕金森综合征(DIP)很常见,其运动症状可能与帕金森病(PD)难以区分。当停药后症状仍持续存在时,这可能代表潜在PD的“暴露”。我们之前报道过,嗅觉减退作为PD常见的非运动特征,与持续性DIP有关。在此,我们报告了连续33例接受多巴胺转运体成像以评估DIP的患者。我们通过比较扫描正常和异常的受试者,研究了潜在多巴胺能去神经支配的临床相关性。33例中有7例(21%)成像异常。扫描正常和异常的患者运动特征相似。30名受试者可进行嗅觉测试,其中27例嗅觉测试结果与成像结果一致(优势比=63;95%置信区间:4.8 - 820;P = 0.002)。嗅觉测试可能是一种简单的筛查方法,有助于识别存在潜在多巴胺能去神经支配的DIP患者,这与早期PD的暴露一致。

相似文献

1
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
2
Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.
Mov Disord. 2016 Mar;31(3):344-51. doi: 10.1002/mds.26456. Epub 2016 Feb 11.
3
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. doi: 10.1016/j.parkreldis.2014.03.024. Epub 2014 Apr 1.
6
Bipolar Disorder and Parkinson's Disease: A I-Ioflupane Dopamine Transporter SPECT Study.
Front Neurol. 2021 Apr 13;12:652375. doi: 10.3389/fneur.2021.652375. eCollection 2021.
7
Drug-induced parkinsonism.
J Clin Neurol. 2012 Mar;8(1):15-21. doi: 10.3988/jcn.2012.8.1.15. Epub 2012 Mar 31.
9
The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism.
J Neurol. 2010 Nov;257(11):1882-9. doi: 10.1007/s00415-010-5631-3. Epub 2010 Jul 16.
10
Comparative Olfactory Profiles in Parkinson's Disease and Drug-Induced Parkinsonism.
J Mov Disord. 2024 Jan;17(1):64-70. doi: 10.14802/jmd.23105. Epub 2023 Oct 6.

引用本文的文献

2
Comparative Olfactory Profiles in Parkinson's Disease and Drug-Induced Parkinsonism.
J Mov Disord. 2024 Jan;17(1):64-70. doi: 10.14802/jmd.23105. Epub 2023 Oct 6.
3
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
5
Olfactory Deficits in the Freezing of Gait Phenotype of Parkinson's Disease.
Front Neurol. 2021 Aug 12;12:656379. doi: 10.3389/fneur.2021.656379. eCollection 2021.
6
Olfactory Testing in Parkinson Disease and REM Behavior Disorder: A Machine Learning Approach.
Neurology. 2021 Apr 13;96(15):e2016-e2027. doi: 10.1212/WNL.0000000000011743. Epub 2021 Feb 24.
8
Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.
Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22.

本文引用的文献

1
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.
Neurology. 2014 Nov 4;83(19):1739-46. doi: 10.1212/WNL.0000000000000960. Epub 2014 Oct 8.
4
Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Int J Neurosci. 2013 Mar;123(3):170-4. doi: 10.3109/00207454.2012.732976. Epub 2013 Jan 4.
5
The role of DAT-SPECT in movement disorders.
J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):5-12. doi: 10.1136/jnnp.2008.157370.
6
Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease.
Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):556-64. doi: 10.1007/s00259-009-1289-4. Epub 2009 Oct 28.
7
Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
Psychiatr Serv. 2009 Sep;60(9):1175-81. doi: 10.1176/ps.2009.60.9.1175.
8
Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism.
J Neurol. 2009 Jun;256(6):910-5. doi: 10.1007/s00415-009-5039-0. Epub 2009 Mar 1.
9
Neuroleptic-induced parkinsonism is associated with olfactory dysfunction.
J Neurol. 2008 Oct;255(10):1574-9. doi: 10.1007/s00415-008-0993-5. Epub 2008 Sep 3.
10
Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1250-2. doi: 10.1136/jnnp.2007.121285. Epub 2007 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验